{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:13:43Z","timestamp":1790648023750,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ahj.2016.08.011","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T06:31:00Z","timestamp":1472797860000},"page":"83-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry"],"prefix":"10.1016","volume":"181","author":[{"given":"Marco","family":"Proietti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Laroche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Drozd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Vijgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragos C.","family":"Cozma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw","family":"Drozdz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo P.","family":"Maggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ahj.2016.08.011_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/09031936.03.00063703","article-title":"Global strategy for the diagnosis, management and prevention of COPD: 2003 update [Internet]","volume":"22","author":"Fabbri","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ahj.2016.08.011_bb0010","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2147\/COPD.S32330","article-title":"Epidemiology of chronic obstructive pulmonary disease: a literature review","volume":"7","author":"Rycroft","year":"2012","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.ahj.2016.08.011_bb0015","series-title":"Global strategy for the diagnosis, management and prevention of COPD. GOLD [Internet]","first-page":"1","year":"2015"},{"issue":"4","key":"10.1016\/j.ahj.2016.08.011_bb0020","first-page":"e38","article-title":"Heart disease and stroke statistics-2016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ahj.2016.08.011_bb0025","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S2213-2600(15)00241-6","article-title":"Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"3","author":"Chen","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.ahj.2016.08.011_bb0030","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.amjcard.2014.04.030","article-title":"Relation of chronic obstructive pulmonary disease to atrial and ventricular arrhythmias","volume":"114","author":"Konecny","year":"2014","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.ahj.2016.08.011_bb0035","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/CIRCULATIONAHA.113.004050","article-title":"Airflow obstruction, lung function, and incidence of atrial fibrillation: the atherosclerosis risk in communities (ARIC) study","volume":"129","author":"Li","year":"2014","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.ahj.2016.08.011_bb0040","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ahj.2016.08.011_bb0045","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jamda.2014.04.009","article-title":"Clinical characteristics and prognostic significance of chronic obstructive pulmonary disease in patients with atrial fibrillation: results from a multicenter atrial fibrillation registry study","volume":"15","author":"Huang","year":"2014","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.ahj.2016.08.011_bb0050","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ijcard.2015.09.062","article-title":"Chronic obstructive pulmonary disease in patients with atrial fibrillation: insights from the ARISTOTLE trial","volume":"202","author":"Durheim","year":"2015","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2016.08.011_bb0055","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1378\/chest.128.4.2068","article-title":"COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program","volume":"128","author":"Sidney","year":"2005","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ahj.2016.08.011_bb0060","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1540-8167.2012.02448.x","article-title":"Impact of chronic obstructive pulmonary disease on procedural outcomes and quality of life in patients with atrial fibrillation undergoing catheter ablation","volume":"24","author":"Gu","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"8","key":"10.1016\/j.ahj.2016.08.011_bb0065","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jacc.2009.11.040","article-title":"Progression from paroxysmal to persistent atrial fibrillation. Clinical correlates and prognosis","volume":"55","author":"de Vos","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2016.08.011_bb0070","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/europace\/eut373","article-title":"A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry","volume":"16","author":"Lip","year":"2014","journal-title":"Europace"},{"issue":"47","key":"10.1016\/j.ahj.2016.08.011_bb0075","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1093\/eurheartj\/ehu374","article-title":"Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry)","volume":"35","author":"Lip","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2016.08.011_bb0080","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/europace\/euv269","article-title":"Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry","volume":"17","author":"Lip","year":"2015","journal-title":"Europace"},{"issue":"2","key":"10.1016\/j.ahj.2016.08.011_bb0085","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ahj.2016.08.011_bb0090","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"issue":"23","key":"10.1016\/j.ahj.2016.08.011_bb0095","first-page":"e199","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"issue":"36","key":"10.1016\/j.ahj.2016.08.011_bb0100","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1093\/eurheartj\/eht192","article-title":"Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services","volume":"34","author":"Hawkins","year":"2013","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ahj.2016.08.011_bb0105","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/eurjhf\/hfs073","article-title":"Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis","volume":"14","author":"Lip","year":"2012","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.ahj.2016.08.011_bb0110","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1183\/09031936.00012408","article-title":"Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD","volume":"32","author":"Mannino","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ahj.2016.08.011_bb0115","first-page":"CD003566","article-title":"Cardioselective beta-blockers for chronic obstructive pulmonary disease (Review)","author":"Ss","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.ahj.2016.08.011_bb0120","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/archinternmed.2010.112","article-title":"Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease","volume":"170","author":"Rutten","year":"2010","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.ahj.2016.08.011_bb0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/thoraxjnl-2015-207251","article-title":"\u03b2-Blockers are associated with a reduction in COPD exacerbations","volume":"71","author":"Bhatt","year":"2016","journal-title":"Thorax"},{"issue":"17","key":"10.1016\/j.ahj.2016.08.011_bb0130","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.jacc.2010.01.024","article-title":"Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease. A randomized crossover trial","volume":"55","author":"Jabbour","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2016.08.011_bb0135","doi-asserted-by":"crossref","first-page":"002197","DOI":"10.1161\/JAHA.115.002197","article-title":"Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF","volume":"5","author":"Pokorney","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2016.08.011_bb0140","article-title":"\u201cReal-world\u201d atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase","author":"Proietti","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.ahj.2016.08.011_bb0145","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s00392-015-0936-y","article-title":"Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial","volume":"105","author":"Proietti","year":"2015","journal-title":"Clin Res Cardiol"},{"issue":"9","key":"10.1016\/j.ahj.2016.08.011_bb0150","doi-asserted-by":"crossref","first-page":"e007824","DOI":"10.1136\/bmjopen-2015-007824","article-title":"Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis","volume":"5","author":"Rothnie","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.ahj.2016.08.011_bb0155","first-page":"qcw005","article-title":"Chronic obstructive pulmonary disease and acute myocardial infarction: effects on presentation, management, and outcomes","author":"Rothnie","year":"2016"},{"key":"10.1016\/j.ahj.2016.08.011_bb0160","first-page":"679","article-title":"Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study)","volume":"7","author":"de Lucas-Ramos","year":"2012","journal-title":"Int J Chron Obstruct Pulmon Dis"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870316301740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870316301740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:57:07Z","timestamp":1757570227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870316301740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":32,"alternative-id":["S0002870316301740"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2016.08.011","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2016.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}